Global Continuous Positive Airway Pressure (CPAP) System Market Strategic Research Report

Scope of the Report

The global Continuous Positive Airway Pressure (CPAP) System market size is predicted to grow from US$ 3,358 million in 2025 to US$ 5,937 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.

Continuous Positive Airway Pressure (CPAP) is a medical device used to treat sleep apnea, a sleep disorder characterized by interrupted breathing and oxygen deprivation during sleep. The CPAP system delivers a constant flow of air pressure to keep the airways open, preventing apneas (pauses in breathing) and improving overall sleep quality.

In 2025, global Continuous Positive Airway Pressure (CPAP) System sales volume reached 4.17 million units, with average price of 783 US$ per unit.

Demand continues to grow as obstructive sleep apnea diagnosis expands. The CPAP machine market is mainly driven by the large and still underdiagnosed obstructive sleep apnea population. Global OSA prevalence has been estimated at nearly 1 billion adults, creating a large long-term treatment pool for CPAP, APAP, and BiPAP devices. Growth is also supported by aging populations, rising obesity rates, higher awareness of sleep-related cardiovascular risks, and wider adoption of home sleep testing, which helps move more patients from diagnosis to device prescription.

Products are shifting toward smart, connected, and patient-friendly CPAP systems. Newer CPAP devices increasingly emphasize cloud connectivity, mobile apps, remote monitoring, automatic pressure adjustment, quieter motors, compact designs, humidification, and better mask comfort. This trend is important because CPAP adherence remains a key challenge: patients often stop therapy due to mask discomfort, dryness, noise, or inconvenience. Telemonitoring and digital follow-up are becoming more common because they can help clinicians identify poor adherence early and improve therapy management.

Competitive structure is being reshaped by recalls, regulation, and brand trust. The Philips Respironics recall that began in 2021 affected CPAP, BiPAP, and ventilator devices, and the FDA reported that the recall involved about 15 million devices worldwide; in April 2024, a U.S. federal court entered a consent decree aimed at patient relief and regulatory compliance. This disrupted supply, damaged trust in affected products, and created opportunities for competitors with stable supply chains and strong connected-device platforms. As a result, buyers and distributors are placing more emphasis on product safety, regulatory compliance, after-sales service, and replacement availability.

Channels are moving from purely clinical sales toward homecar

This report presents a comprehensive overview of the global Continuous Positive Airway Pressure (CPAP) System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• CPAP (Continuous Positive Airway Pressure)
• APAP (Automatic Positive Airway Pressure)
• BiPAP (Bilevel Positive Airway Pressure)

Segment by Pressure Mode

• Fixed-pressure CPAP Machine
• Auto-adjusting CPAP Machine

Segment by Portability

• Standard CPAP Machine
• Travel CPAP Machine

Segment by Application

• Hospital
• Home Care

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Continuous Positive Airway Pressure (CPAP) System market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Home Care evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact